Annual Drug Patent Expirations for MAKENA+%28AUTOINJECTOR%29
Makena (autoinjector) is a drug marketed by Covis and is included in one NDA. It is available from two suppliers. There are ten patents protecting this drug.
Drug patent litigation for MAKENA (AUTOINJECTOR).
This drug has thirty-nine patent family members in thirteen countries.
The generic ingredient in MAKENA (AUTOINJECTOR) is hydroxyprogesterone caproate. Two suppliers are listed for this compound. Additional details are available on the hydroxyprogesterone caproate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
